Kaye PM - Search Results

1

Post kala-azar dermal leishmaniasis: an unresolved mystery.

Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M. Mukhopadhyay D, et al. Among authors: kaye pm. Trends Parasitol. 2014 Feb;30(2):65-74. doi: 10.1016/j.pt.2013.12.004. Epub 2014 Jan 2. Trends Parasitol. 2014. PMID: 24388776 Free PMC article. Review.

2

Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.

Engwerda CR, Ato M, Kaye PM. Engwerda CR, et al. Among authors: kaye pm. Trends Parasitol. 2004 Nov;20(11):524-30. doi: 10.1016/j.pt.2004.08.009. Trends Parasitol. 2004. PMID: 15471704 Review.

3

Postgenomic research on leishmaniasis: a critical self-appraisal.

Kaye PM, Blackwell JM. Kaye PM, et al. Trends Parasitol. 2008 Sep;24(9):401-5. doi: 10.1016/j.pt.2008.06.004. Epub 2008 Aug 4. Trends Parasitol. 2008. PMID: 18684668 Free PMC article.

4

VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis.

Stanley AC, Dalton JE, Rossotti SH, MacDonald KP, Zhou Y, Rivera F, Schroder WA, Maroof A, Hill GR, Kaye PM, Engwerda CR. Stanley AC, et al. Among authors: kaye pm. PLoS Pathog. 2008 Sep 19;4(9):e1000158. doi: 10.1371/journal.ppat.1000158. PLoS Pathog. 2008. PMID: 18802456 Free PMC article.

5

Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice.

Dalton JE, Maroof A, Owens BM, Narang P, Johnson K, Brown N, Rosenquist L, Beattie L, Coles M, Kaye PM. Dalton JE, et al. Among authors: kaye pm. J Clin Invest. 2010 Apr;120(4):1204-16. doi: 10.1172/JCI41281. Epub 2010 Mar 15. J Clin Invest. 2010. PMID: 20234089 Free PMC article.

6

Immunomodulators: use in combined therapy against leishmaniasis.

Dalton JE, Kaye PM. Dalton JE, et al. Among authors: kaye pm. Expert Rev Anti Infect Ther. 2010 Jul;8(7):739-42. doi: 10.1586/eri.10.64. Expert Rev Anti Infect Ther. 2010. PMID: 20586558 No abstract available.

7

Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver.

Beattie L, Phillips R, Brown N, Owens BM, Chauhan N, Dalton JE, Kaye PM. Beattie L, et al. Among authors: kaye pm. Infect Immun. 2011 Mar;79(3):1057-66. doi: 10.1128/IAI.00633-10. Epub 2010 Dec 13. Infect Immun. 2011. PMID: 21149596 Free PMC article.

8

Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis.

Yurdakul P, Dalton J, Beattie L, Brown N, Erguven S, Maroof A, Kaye PM. Yurdakul P, et al. Among authors: kaye pm. Am J Pathol. 2011 Jul;179(1):23-9. doi: 10.1016/j.ajpath.2011.03.009. Epub 2011 Apr 30. Am J Pathol. 2011. PMID: 21703391 Free PMC article.

9

Visceral leishmaniasis: immunology and prospects for a vaccine.

Kaye PM, Aebischer T. Kaye PM, et al. Clin Microbiol Infect. 2011 Oct;17(10):1462-70. doi: 10.1111/j.1469-0691.2011.03610.x. Epub 2011 Aug 18. Clin Microbiol Infect. 2011. PMID: 21851483 Free article. Review.

10

B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis.

Moore JW, Beattie L, Dalton JE, Owens BM, Maroof A, Coles MC, Kaye PM. Moore JW, et al. Among authors: kaye pm. PLoS One. 2012;7(3):e34143. doi: 10.1371/journal.pone.0034143. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters